Aims Cardiac tissue engineering has been proposed as an appropriate method to repair
myocardial infarction (MI). Evidence suggests that a cell with scaffold combination was more …

Little is known about the cardioprotective effects against heart failure (HF), the effects on
differentiation of bone marrow-derived mononuclear cell (BMMNC), and the biocompatibility …

The combination of scaffold material and cell transplantation therapy has been extensively
investigated in cardiac tissue engineering. However, many polymers are difficult to …

The use of mesenchymal stem cells (MSCs) for tissue regeneration is often hampered by
modest engraftment in host tissue. This study was designed to quantitatively compare MSCs …

Growing three-dimensional scaffolds that contain more than a few layers of seeded cells is
crucial for the creation of thick and viable cardiac tissues. To achieve this goal, a …

Cardiac tissue engineering approaches can deliver large numbers of cells to the damaged
myocardium and have thus increasingly been considered as a possible curative treatment to …

Background—Cardiac cell transplantation is limited by poor graft viability. We aimed to
enhance the survival of transplanted cardiomyoblasts using growth factor-supplemented …

Myocardial infarction (MI) leads to the loss of cardiomyocytes, followed by left ventricular
(LV) remodeling and cardiac dysfunction. The authors hypothesize that an elastic …

Various cell delivery methods have been investigated for cell transplantation treatment of
cardiac infarcts. In this study, we investigated a type I collagen–glycosaminoglycan (GAG) …

Bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid (BMSC/SH) patches were
implanted into myocardial infarction (MI) rat hearts to investigate the efficacies of them on …